Skip to main content

Published locations for Adding obinutuzumab to bendamustine boosts progression-free survival in rituximab-refractory indolent non-Hodgkin lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding obinutuzumab to bendamustine boosts progression-free survival in rituximab-refractory indolent non-Hodgkin lymphoma

User login

  • Reset your password
  • /content/adding-obinutuzumab-bendamustine-boosts-progression-free-survival-rituximab-refractory
  • /hematologynews/article/109944/indolent-lymphoma/adding-obinutuzumab-bendamustine-boosts-progression
  • /oncologypractice/article/109944/indolent-lymphoma/adding-obinutuzumab-bendamustine-boosts
  • /hematologynews/nhlhub/article/109944/indolent-lymphoma/adding-obinutuzumab-bendamustine-boosts
  • /hematology-oncology/article/109944/indolent-lymphoma/adding-obinutuzumab-bendamustine-boosts